3,441 results on '"Ludolph, Albert C."'
Search Results
2. Clinical spreading of muscle weakness in amyotrophic lateral sclerosis (ALS): a study in 910 patients
3. AI-assisted automatic MRI-based tongue volume evaluation in motor neuron disease (MND)
4. Myelitis as a side effect of tofersen therapy in SOD1-associated ALS
5. Neurological manifestation of HEV infection: still a rare disease entity?
6. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany
7. Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers
8. The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe
9. AI-assisted quantification of hypothalamic atrophy in amyotrophic lateral sclerosis by convolutional neural network-based automatic segmentation
10. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes
11. Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value
12. Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI
13. Mitochondrial genome study in blood of maternally inherited ALS cases
14. Impaired ATF3 signaling involves SNAP25 in SOD1 mutant ALS patients
15. Patterns of synaptic loss in human amyotrophic lateral sclerosis spinal cord: a clinicopathological study
16. Quality of life and depression in patients with amyotrophic lateral sclerosis – does the country of origin matter?
17. Integrative genetic analysis illuminates ALS heritability and identifies risk genes
18. Structural parameters are superior to eigenvector centrality in detecting progressive supranuclear palsy with machine learning & multimodal MRI
19. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
20. The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
21. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
22. Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis
23. Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry
24. Clinical and paraclinical features of first unprovoked seizures in the elderly
25. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
26. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
27. Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis
28. Religiosity in patients with amyotrophic lateral sclerosis, a cross-country comparison
29. A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity
30. Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis
31. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
32. Neuropeptide FF (NPFF)-positive nerve cells of the human cerebral cortex and white matter in controls, selected neurodegenerative diseases, and schizophrenia
33. Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design
34. Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex
35. ALS is imprinted in the chromatin accessibility of blood cells
36. Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study
37. Increased NF-L levels in the TDP-43G298S ALS mouse model resemble NF-L levels in ALS patients
38. Blood–CSF barrier integrity in amyotrophic lateral sclerosis
39. Non-canonical adrenergic neuromodulation of motoneuron intrinsic excitability through beta-receptors in wild-type and ALS mice
40. Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational study
41. Body fat compartment determination by encoder–decoder convolutional neural network: application to amyotrophic lateral sclerosis
42. Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases
43. Stress induced TDP-43 mobility loss independent of stress granules
44. Involvement of cortico-efferent tracts in flail arm syndrome: a tract-of-interest-based DTI study
45. The spectrum and differential diagnosis of acquired ocular motor nerve palsies: a clinical study of 502 patients
46. Blood GFAP as an emerging biomarker in brain and spinal cord disorders
47. Neuropsychological deficits have only limited impact on psychological well-being in amyotrophic lateral sclerosis
48. Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum
49. Methylome analysis of ALS patients and presymptomatic mutation carriers in blood cells
50. FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.